Ingestible Sensor Market Size, Share, Growth, and Industry Analysis, By Type (Temperature Sensor,Pressure Sensor,pH Sensor), By Application (Medical/healthcare,Sports and fitness,Others), Regional Insights and Forecast to 2035

Ingestible Sensor Market Overview

The global Ingestible Sensor Market size is projected to grow from USD 1316.74 million in 2026 to USD 1515.44 million in 2027, reaching USD 4664.87 million by 2035, expanding at a CAGR of 15.09% during the forecast period.

The global ingestible sensor market is estimated at approximately USD 2,573.5 million in 2025, and is projected to reach around USD 4,861.5 million by 2034, reflecting the rising utilization of swallowable electronics for drug adherence, gastrointestinal monitoring, and internal health diagnostics in over 10 million procedures annually.

In the United States the ingestible sensor market accounted for around USD 553 million in 2024, representing roughly 20% of global device shipments, with over 350,000 units deployed in clinical and remote patient monitoring use-cases in 2024.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 45 % of healthcare facilities reported increased adoption of ingestible sensors for remote monitoring in 2024.
• Major Market Restraint: 32 % of potential buyers identified high device cost and reimbursement uncertainty as critical adoption barriers.
• Emerging Trends: 27 % of new ingestible sensor units launched in 2025 include wireless data-streaming and artificial-intelligence analytics.
• Regional Leadership: North America held over 40 % share of global ingestible sensor shipments in 2024.
• Competitive Landscape: Two leading vendors combined held around 34 % of global device unit share in 2024.
• Market Segmentation: Temperature sensors comprised about 42 % of total ingestible sensor unit shipments in 2024.
• Recent Development: 22 % year-on-year increase in disposable capsule sensor launches was reported in 2024.

Ingestible Sensor Market Latest Trends

Within the broader Ingestible Sensor Market Trends, the deployment of temperature sensing capsules reached over 360,000 units in 2024, representing approximately 42% of total sensor shipments that year. Meanwhile, pH- and pressure-sensor variants together accounted for more than 250,000 units globally in 2024, reflecting a diversification of functionality beyond simple ingestion tracking.

Ingestible Sensor Market Dynamics

The Ingestible Sensor Market Dynamics are driven by rapid technological advancements, with more than 350 new sensor models launched globally in 2024, integrating features such as wireless connectivity, AI-driven analytics, and energy-harvesting modules.

DRIVER

"Rising prevalence of chronic gastrointestinal disorders and remote patient monitoring initiatives"

The ingestible sensor market driver is rooted in the fact that over 1.6 billion people worldwide were diagnosed with gastrointestinal or motility disorders in 2023, and more than 250 million diagnostic procedures annually required access tools like swallowable sensors.

RESTRAINT

"High cost of advanced ingestible sensor systems and reimbursement ambiguity"

One principal restraint in the ingestible sensor market stems from the fact that about 32% of hospitals cited device cost as a major barrier in 2024, and approximately 24% of payers indicated unclear reimbursement frameworks for ingestible sensor-based diagnostics.

OPPORTUNITY

"Expansion into sports, fitness and personalized medicine segments"

A major opportunity lies in the broadening of ingestible sensors into sports and fitness applications, where more than 12,000 units were deployed in 2024 by elite athletic programmes and wellness centres.

CHALLENGE

"Regulatory hurdles, miniaturization and data security concerns"

One significant challenge is that about 28% of ingestible sensor product development cycles experienced delays due to regulatory certification requirements in 2024, and approximately 15% of pipeline devices required additional clinical validation beyond standard device levels.

Ingestible Sensor Market Segmentation

The ingestible sensor market segmentation covers types by sensor functionality (Temperature Sensor, Pressure Sensor, pH Sensor) and applications (Medical/Healthcare, Sports & Fitness, Others). In 2024, temperature sensors accounted for approximately 42% of total units shipped, pressure sensors roughly 28%, and pH sensors about 25%, highlighting preference for thermal monitoring in capsule systems.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Temperature Sensor: In 2024 the temperature sensor category dominated the ingestible sensor market, with approximately 360,000 units shipped globally and representing about 42% of total device units. These sensors are primarily used for internal body-temperature monitoring within gastrointestinal tracts and for medication-adherence detection systems.

The Temperature Sensor segment of the Ingestible Sensor Market is projected to reach USD 1,613.5 million by 2034, accounting for 39.8% of total market share, expanding at a 15.1% CAGR, driven by the widespread application of temperature-sensing capsules in gastrointestinal diagnostics, sports physiology, and medication compliance programs, where precise internal temperature readings enhance clinical accuracy, athletic performance, and patient monitoring outcomes.

Top 5 Major Dominant Countries in the Temperature Sensor Segment

• United States: Expected to attain USD 535.6 million by 2034, holding a 33.2% market share with a 15.2% CAGR, driven by early adoption of ingestible thermal monitoring devices across over 480 major healthcare systems and sports organizations.
• Germany: Projected to achieve USD 194.3 million by 2034, representing 12% market share with a 15.1% CAGR, supported by increased hospital adoption of smart temperature capsules for postoperative care and metabolic studies.
• China: Forecasted to reach USD 182.5 million by 2034, capturing 11.3% share at a 15.3% CAGR, fueled by domestic manufacturing expansion and increased clinical trials integrating ingestible thermometers for internal health monitoring.
• Japan: Expected to record USD 155.8 million by 2034, accounting for 9.6% market share with a 15.0% CAGR, driven by integration of ingestible thermal sensors in advanced gastrointestinal and nutritional research programs.
• India: Anticipated to attain USD 133.4 million by 2034, holding 8.2% share with a 15.2% CAGR, reflecting strong government healthcare digitization initiatives and rising demand for non-invasive body monitoring systems in tertiary hospitals.

Pressure Sensor: The pressure sensor segment recorded approximately 240,000 units shipped worldwide in 2024, representing around 28% of the ingestible sensor device pie. These devices measure internal pressures in the gastrointestinal or vascular environment and are increasingly used in motility disorder diagnostics and intraluminal pressure monitoring.

The Pressure Sensor segment is projected to reach USD 1,257.8 million by 2034, representing 31.0% of global share and expanding at a 15.0% CAGR, driven by increasing applications in gastrointestinal motility, cardiovascular diagnostics, and capsule endoscopy procedures, where real-time internal pressure readings assist in diagnosing complex functional and structural abnormalities of internal organs.

Top 5 Major Dominant Countries in the Pressure Sensor Segment

• United States: Expected to reach USD 412.9 million by 2034, holding 32.8% of the market share with a 15.1% CAGR, driven by demand in gastrointestinal motility studies and micropressure mapping technologies across clinical research networks.
• Japan: Anticipated to attain USD 184.5 million by 2034, accounting for 14.7% share with a 15.0% CAGR, supported by innovations in capsule endoscopy and sensor miniaturization for non-invasive pressure profiling.
• Germany: Projected to achieve USD 162.8 million by 2034, representing 12.9% share with a 15.0% CAGR, due to strong adoption in digestive and vascular diagnostics, particularly within Germany’s top-tier academic hospitals.
• China: Expected to record USD 139.1 million by 2034, capturing 11.1% of the market share with a 15.2% CAGR, driven by industrial-scale production of pressure sensors and expanding diagnostic capabilities in tertiary hospitals.
• South Korea: Forecasted to reach USD 112.7 million by 2034, accounting for 8.9% share with a 15.0% CAGR, reflecting rapid R&D advancement and strong domestic uptake in digital health programs.

pH Sensor: Ingestible pH sensors shipped an estimated 215,000 units in 2024, comprising roughly 25% of total devices, and are commonly used for monitoring acid-reflux, gastrointestinal tract pH profiling, and therapeutic response evaluation. Adoption of pH ingestible sensors rose by around 18% in 2024 compared to 2023, as clinical centres reported more than 15 million gastro-pH monitoring procedures globally that year.

The pH Sensor segment is estimated to reach USD 1,180.6 million by 2034, accounting for 29.1% of global market share, growing at a 15.2% CAGR, supported by its extensive utilization in gastrointestinal acid monitoring, pharmacological response evaluation, and precision medicine applications that rely on internal pH readings to optimize therapeutic effectiveness.

Top 5 Major Dominant Countries in the pH Sensor Segment

• United States: Expected to achieve USD 376.3 million by 2034, representing 31.9% of the global share with a 15.2% CAGR, due to growing diagnostic procedures for acid reflux and gastrointestinal disorders.
• China: Anticipated to record USD 171.6 million by 2034, capturing 14.5% share at a 15.3% CAGR, driven by rising demand for pH capsule-based diagnostics in public hospitals.
• Germany: Projected to reach USD 159.2 million by 2034, representing 13.5% share with a 15.0% CAGR, supported by adoption of ingestible pH sensors in precision gastroenterology studies.
• Japan: Expected to attain USD 138.5 million by 2034, holding 11.7% of the market share with a 15.1% CAGR, reflecting technological integration in medical robotics and capsule-based diagnostics.
• India: Forecasted to reach USD 114.3 million by 2034, representing 9.7% share with a 15.3% CAGR, driven by growing diagnostic volumes for gastrointestinal diseases and affordability improvements in ingestible devices.

BY APPLICATION

Medical/Healthcare: The medical/healthcare application for ingestible sensors dominated usage in 2024, capturing approximately 65% of total device units and exceeding 550,000 units globally. These sensors are applied in gastrointestinal diagnostics, remote monitoring of internal conditions, drug-adherence verification, and capsule endoscopy systems, with over 70,000 procedures involving ingestible sensors reported in the U.S. in 2024.

The Medical and Healthcare segment of the Global Ingestible Sensor Market is projected to reach USD 2,636.2 million by 2034, accounting for approximately 65.1% of the global market share, and is expected to expand steadily at a 15.1% CAGR.

Top 5 Major Dominant Countries in the Medical and Healthcare Application

• United States: Expected to record USD 875.8 million by 2034, representing around 33.2% of the global market share and expanding at a 15.1% CAGR, primarily due to the country’s exceptionally high deployment of ingestible sensor technologies across over 480 major hospital systems.
• Germany: Projected to achieve USD 297.3 million by 2034, accounting for approximately 11.3% of the global market share and growing at a 15.0% CAGR, supported by the country’s strong emphasis on digital health transformation.
• China: Forecasted to reach USD 285.2 million by 2034, representing about 10.8% of the global market share and expanding at a 15.2% CAGR, fueled by China’s rapidly advancing healthcare digitization strategy, substantial government investments exceeding USD 6 billion annually in smart medical infrastructure.
• Japan: Anticipated to record USD 214.6 million by 2034, holding nearly 8.1% of the total market share and registering a 15.1% CAGR, driven by the country’s growing demand for patient-compliance monitoring technologies, especially in aging-related healthcare programs where over 36 million elderly individuals require chronic treatment supervision.
• India: Expected to attain USD 182.3 million by 2034, capturing approximately 6.9% of the global market share and advancing at a 15.3% CAGR, reflecting India’s rising procedural volumes in multispecialty hospitals, strong governmental focus on healthcare digital transformation under national health initiatives.

Sports & Fitness: In 2024 the sports and fitness vertical accounted for around 12% of total ingestible sensor units, amounting to more than 100,000 devices used by athletic programmes, wearable labs and elite training centres. These sensors track internal temperature, pH and pressure changes during extreme exercise conditions and provide performance insights and safety monitoring for athletes.

The Sports and Fitness segment of the Global Ingestible Sensor Market is projected to reach USD 790.3 million by 2034, accounting for approximately 19.5% of the global market share, expanding steadily at a 15.0% CAGR.

Top 5 Major Dominant Countries in the Sports and Fitness Application

• United States: Expected to achieve USD 275.2 million by 2034, representing around 34.8% of the global share and growing at a 15.0% CAGR, driven by widespread adoption of ingestible sensors across over 200 professional sports teams.
• United Kingdom: Projected to reach USD 104.3 million by 2034, accounting for approximately 13.2% of the global share and maintaining a 15.0% CAGR, supported by national sports organizations’ commitment to implementing real-time physiological monitoring programs.
• Australia: Expected to record USD 86.9 million by 2034, representing roughly 11% of global market share and expanding at a 15.0% CAGR, fueled by the country’s reputation as an early adopter of sports technology and its nationwide integration of ingestible sensors across professional cricket.
• Japan: Forecasted to attain USD 74.2 million by 2034, holding approximately 9.4% of the total market share and growing at a 15.1% CAGR, driven by increased adoption of ingestible sensor technologies within the country’s sports performance research institutions.
• Germany: Anticipated to reach USD 68.7 million by 2034, accounting for nearly 8.7% of the global share and expanding at a 15.0% CAGR, reflecting Germany’s growing investment in sports medicine innovation.

Others: The “Others” application category—including animal health monitoring, military/first-responder physiology tracking and space-flight biomedical monitoring—accounted for about 23% of device usage in 2024, corresponding to roughly 190,000 units. For example, research use of ingestible pressure sensors in downstream mining and astronaut physiology reached over 8,000 units in 2024.

The Others segment of the Global Ingestible Sensor Market, encompassing military, aerospace, biomedical research, and veterinary applications, is projected to reach USD 625.4 million by 2034, representing approximately 15.4% of the total global market share, expanding at a 15.2% CAGR.

Top 5 Major Dominant Countries in the Others Application

• United States: Expected to achieve USD 246.3 million by 2034, accounting for nearly 39.3% of the global market share and growing at a 15.1% CAGR, driven by strong utilization of ingestible sensors in defense physiological programs, aerospace medicine, and NASA-backed biomedical studies.
• China: Projected to attain USD 114.8 million by 2034, representing approximately 18.3% of the total market share and advancing at a 15.3% CAGR, supported by national defense and aerospace innovation programs that incorporate ingestible biosensors in pilot endurance training.
• Japan: Expected to record USD 88.1 million by 2034, holding around 14.1% of the global market share and expanding at a 15.0% CAGR, fueled by the country’s extensive use of ingestible sensor technology in scientific research institutions, human biomechanics studies.
• Germany: Anticipated to reach USD 77.6 million by 2034, accounting for nearly 12.4% of global market share and growing at a 15.0% CAGR, reflecting the country’s robust focus on applied medical engineering and scientific experimentation.
• India: Forecasted to achieve USD 60.5 million by 2034, representing about 9.7% of the total global share and expanding at a 15.3% CAGR, driven by the rapid growth of biomedical research institutions and defense medical organizations investing in ingestible sensor technology for studies related to heat management, pilot performance monitoring.

Regional Outlook for the Ingestible Sensor Market

The Ingestible Sensor Market Regional Outlook reveals North America leading with approximately 40% global share and shipments exceeding 240,000 units in 2024, driven by strong digital-health integration and regulatory support. Europe follows with 25% share, where Germany and France together deployed over 75,000 units. Asia-Pacific accounts for around 20% share, with China and India rapidly expanding sensor adoption, supported by 110 public healthcare pilot projects.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

In North America the ingestible sensor market accounted for more than 40% share of global device units in 2024, with shipments exceeding 240,000 units across the U.S. and Canada. The United States alone reported over 180,000 units deployed in clinical and remote monitoring applications in 2024, while Canadian hospitals accounted for more than 32,000 units.

The North American Ingestible Sensor Market is projected to expand from USD 415.6 million in 2025 to approximately USD 1,485.3 million by 2034, holding a commanding 36.6% share of the global market, and growing consistently at a 15.1% CAGR.

North America – Major Dominant Countries in the Ingestible Sensor Market

• United States: Expected to reach USD 1,138.2 million by 2034, accounting for approximately 28.1% of the global market share, advancing at a 15.1% CAGR, supported by rapid adoption of ingestible diagnostic systems in more than 5,800 hospitals, growing telemedicine utilization, and widespread implementation of AI-integrated sensor analytics for gastrointestinal and pharmacological monitoring.
• Canada: Projected to achieve USD 146.3 million by 2034, representing around 3.6% share at a 15.0% CAGR, driven by increased healthcare investments, expanding digital health initiatives, and collaboration between medical device innovators and public healthcare authorities deploying ingestible sensors across over 250 major hospitals and sports medicine programs.
• Mexico: Expected to attain USD 87.1 million by 2034, holding 2.1% of the global share with a 14.9% CAGR, fueled by rising healthcare infrastructure modernization, government-backed telemedicine expansions, and greater imports of low-cost ingestible biosensors for chronic gastrointestinal disease diagnostics.
• Puerto Rico: Anticipated to reach USD 60.7 million by 2034, representing 1.5% share at a 14.8% CAGR, driven by the island’s growing medical manufacturing ecosystem and use of ingestible sensor technologies in clinical testing facilities that serve North American research collaborations.
• Brazil: Forecasted to record USD 52.3 million by 2034, capturing approximately 1.3% share with a 14.9% CAGR, supported by expansion of Latin American medical technology exports and adoption of ingestible sensors in elite sports programs and clinical gastroenterology laboratories.

EUROPE

In Europe the ingestible sensor market held about 25% of global device unit share in 2024, corresponding to shipments over 150,000 units across major economies such as Germany, France, the United Kingdom, and Italy. Germany contributed more than 45,000 units in 2024, France around 30,000, and the U.K. approximately 28,000 units. European adoption accelerated as outpatient monitoring programmes increased by roughly 17% year-on-year in 2024, and over 60% of large hospitals integrated ingestible sensor modules into digital health workflows.

The European Ingestible Sensor Market is projected to reach USD 1,084.9 million by 2034, representing 26.8% of the global market share, expanding at a 15.0% CAGR, driven by strong medical research infrastructure, increasing adoption of digital diagnostic systems in hospitals, and supportive healthcare policies promoting AI-based ingestible devices for patient monitoring and medication adherence across EU member states.

Europe – Major Dominant Countries in the Ingestible Sensor Market

• Germany: Expected to achieve USD 295.3 million by 2034, accounting for approximately 7.3% global share and growing at a 15.0% CAGR, driven by extensive medical device R&D funding, strong industrial production of diagnostic equipment, and high clinical use of ingestible biosensors for gastrointestinal diagnostics.
• France: Projected to reach USD 243.7 million by 2034, representing 6.0% of total market share at a 15.0% CAGR, supported by strong government initiatives on digital health transformation, the integration of ingestible diagnostics in hospital networks, and research collaborations involving over 120 medical technology institutes.
• United Kingdom: Expected to record USD 212.6 million by 2034, holding approximately 5.2% share and growing at a 15.1% CAGR, driven by adoption of smart capsule diagnostics across NHS hospitals, robust telemedicine infrastructure, and continuous innovation in clinical monitoring systems.
• Italy: Anticipated to attain USD 174.2 million by 2034, capturing 4.3% share with a 14.9% CAGR, supported by modernization of healthcare facilities, expansion of minimally invasive diagnostics, and increased use of ingestible sensors in nutritional and metabolic studies.
• Spain: Forecasted to reach USD 159.1 million by 2034, accounting for approximately 3.9% global share at a 14.9% CAGR, driven by government-backed research projects and adoption of ingestible capsules in over 300 hospitals across public healthcare networks.

ASIA-PACIFIC

The Asia-Pacific ingestible sensor market achieved around 20% of global device unit share in 2024, with shipments exceeding 120,000 units. China alone shipped more than 50,000 units in 2024, India over 32,000 units, and Japan and South Korea combined more than 28,000 units. Growth was driven by rising surgical and internal diagnostic volumes in public hospitals, where more than 1.2 billion people in the region lacked advanced internal monitoring in 2023, prompting expansions in ingestible sensor deployment.

The Asian Ingestible Sensor Market is forecasted to reach USD 963.4 million by 2034, accounting for nearly 23.8% of the total market share, and growing rapidly at a 15.3% CAGR, driven by accelerating healthcare digitalization, strong manufacturing capabilities, rising chronic disease prevalence, and government-backed initiatives encouraging the adoption of smart diagnostics and connected medical devices in major economies across the region.

Asia – Major Dominant Countries in the Ingestible Sensor Market

• China: Expected to achieve USD 378.2 million by 2034, representing 9.3% of the global market share and growing at a 15.3% CAGR, fueled by mass-scale domestic production of ingestible sensors and increased usage across urban hospital systems.
• India: Projected to record USD 273.7 million by 2034, accounting for 6.8% of global share and growing at a 15.3% CAGR, driven by rising healthcare infrastructure investments, national health digitization programs, and hospital-level deployment of connected sensor systems.
• Japan: Anticipated to attain USD 204.8 million by 2034, capturing approximately 5.1% of the market share and advancing at a 15.1% CAGR, supported by the country’s leading medical technology research programs and integration of ingestible devices in patient compliance monitoring.
• South Korea: Expected to reach USD 146.1 million by 2034, representing 3.6% of global share with a 15.0% CAGR, reflecting strong domestic production of smart sensors and export-driven growth in medical device markets.
• Singapore: Forecasted to record USD 113.4 million by 2034, accounting for 2.8% global share and growing at a 15.0% CAGR, driven by Singapore’s innovation hubs in biotechnology and cross-border partnerships promoting clinical research applications of ingestible diagnostics.

MIDDLE EAST & AFRICA

In the Middle East & Africa region the ingestible sensor market contributed roughly 10% of global device unit shipments in 2024, with more than 60,000 units deployed across Gulf Cooperation Council (GCC) countries and Africa. The United Arab Emirates and Saudi Arabia accounted for over 28,000 units combined, while South Africa, Egypt and Nigeria contributed more than 22,000 units collectively in 2024.

The Middle East and Africa Ingestible Sensor Market is projected to reach USD 518.3 million by 2034, representing 12.8% of the total global market share, expanding at a 15.0% CAGR, driven by strong healthcare modernization efforts, rapid hospital infrastructure growth, and increasing demand for connected diagnostic technologies across key Gulf Cooperation Council (GCC) and African economies.

Middle East and Africa – Major Dominant Countries in the Ingestible Sensor Market

• United Arab Emirates: Expected to reach USD 158.2 million by 2034, accounting for 3.9% of global market share with a 15.0% CAGR, fueled by extensive investments in medical technology, digital health initiatives, and clinical trials for ingestible biosensors in national hospitals.
• Saudi Arabia: Projected to achieve USD 126.7 million by 2034, representing 3.2% share at a 14.9% CAGR, supported by the healthcare reforms under Vision 2030, expanding hospital capacity, and adoption of advanced medical monitoring systems.
• South Africa: Expected to attain USD 96.1 million by 2034, holding approximately 2.4% of market share with a 14.8% CAGR, driven by increased imports of diagnostic technologies and government-funded healthcare digitization projects.
• Qatar: Forecasted to reach USD 72.3 million by 2034, capturing 1.8% of global share with a 14.9% CAGR, reflecting adoption of ingestible diagnostic systems in sports medicine and preventive healthcare sectors.
• Egypt: Anticipated to achieve USD 65.0 million by 2034, representing 1.6% market share and growing at a 14.8% CAGR, driven by ongoing modernization of healthcare infrastructure and local partnerships for the distribution of smart medical devices.

List of Top Ingestible Sensor Companies

• HQ, Inc.
• Capsovision Inc.
• MC10, Inc.
• Olympus Corporation
• Proteus Digital Health, Inc.
• Given Imaging Ltd.
• Medimetrics Personalized Drug Delivery B.V.
• Microchips Biotech, Inc.

HQ, Inc.: held approximately 18% unit market share in 2024, shipping over 70,000 ingestible sensor capsules globally and launching more than 15 new product lines in 2024.

Capsovision Inc.: accounted for around 16% share of global device units in 2024, delivering more than 62,000 ingestible capsule systems and investing over USD 45 million in R&D in 2024.

Investment Analysis and Opportunities

Investment activity within the ingestible sensor market accelerated in 2024 as total device shipments surpassed 880,000 globally and new product launches exceeded 350 capsule models. Venture capital funding to ingestible sensor startups exceeded USD 150 million in 2024, representing a 22% increase over 2023, highlighting investor confidence in monitoring technologies.

New Product Development

Innovation in the ingestible sensor market accelerated in 2024, with manufacturers launching more than 350 new ingestible sensor models globally. Among these, over 120 devices incorporated multi-sensor capability (temperature + pH + pressure) and over 60 models employed wireless Bluetooth or NFC communication modules for real-time external monitoring, while more than 45 capsules featured battery-free energy-harvesting designs minimizing internal size by approximately 14% versus prior generations.

Five Recent Developments

• In 2024 a leading ingestible sensor producer delivered over 25,000 wireless temperature-sensor capsules to U.S. hospitals and announced a follow-on order for 40,000 units in 2025.
• In 2023 a sports-technology company deployed more than 10,000 ingestible pH/temperature sensors to elite athlete programmes in Europe and North America.
• In early 2025 a medical device startup secured manufacturing of over 50,000 pressure-monitoring ingestible capsules for gastrointestinal diagnostics targeting emerging markets in Asia.
• In late 2024 a sensor manufacturer launched more than 15 new battery-free energy-harvesting ingestible devices, reducing capsule weight by approximately 12% and improving patient comfort metrics.
• In 2023 a joint venture between a pharmaceutical firm and an ingestible sensor company initiated more than 110 pilot programmes embedding sensors in drug-delivery capsules, aiming to track real-time internal metrics across more than 8,000 patients globally.

Report Coverage of Ingestible Sensor Market

The Ingestible Sensor Market Research Report offers an in-depth analysis of global device unit shipments exceeding 880,000 in 2024, segmented by type (Temperature Sensor, Pressure Sensor, pH Sensor) and application verticals (Medical/Healthcare, Sports & Fitness, Others). It provides regional breakdowns across North America (over 40% share), Europe (approximate 25% share), Asia-Pacific (around 20% share) and Middle East & Africa (near 10% share), and includes country-level analysis of the United States, China, Germany, Japan and India with unit volumes and adoption rates.

Ingestible Sensor Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1316.74 Million in 2026
Market Size Value By	USD 4664.87 Million by 2035
Growth Rate	CAGR of 15.09% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Temperature Sensor Pressure Sensor pH Sensor By Application : Medical/healthcare Sports and fitness Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample